SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013341
Filing Date
2020-11-09
Accepted
2020-11-09 16:03:13
Documents
87
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20200930x10q.htm   iXBRL 10-Q 2442200
2 EX-31.1 icpt-20200930xex31d1.htm EX-31.1 9904
3 EX-31.2 icpt-20200930xex31d2.htm EX-31.2 9886
4 EX-32.1 icpt-20200930xex32d1.htm EX-32.1 10411
  Complete submission text file 0001558370-20-013341.txt   8861415

Data Files

Seq Description Document Type Size
5 EX-101.SCH icpt-20200930.xsd EX-101.SCH 51424
6 EX-101.CAL icpt-20200930_cal.xml EX-101.CAL 68972
7 EX-101.DEF icpt-20200930_def.xml EX-101.DEF 156050
8 EX-101.LAB icpt-20200930_lab.xml EX-101.LAB 413254
9 EX-101.PRE icpt-20200930_pre.xml EX-101.PRE 362010
10 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20200930x10q_htm.xml XML 1789292
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 201297646
SIC: 2834 Pharmaceutical Preparations